Lack of correlation between in vitro and in vivo studies of combinations of rifampin plus vancomycin or beta-lactam antibiotics against Streptococcus pneumoniae.
Tuban
F
F
Cabellos
C
C
Liñares
J
J
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D000904:Antibiotics, Antitubercular / Q000494:pharmacology; D004359:Drug Therapy, Combination / Q000494:pharmacology*; D066298:In Vitro Techniques; D008826:Microbial Sensitivity Tests; D011817:Rabbits; D012293:Rifampin / Q000494:pharmacology; D013296:Streptococcus pneumoniae / Q000187:drug effects*; D014640:Vancomycin / Q000494:pharmacology; D047090:beta-Lactams
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D047090:beta-Lactams; D014640:Vancomycin; D012293:Rifampin